Interestingly, stromal localization and the levels of active SMAD2 (SE = 2.1) and ITGA5/ITGB1 distinguish patient-protective from patient-detrimental desmoplasia and foretell tumor recurrences. Here, ITGB1 is linked to neoplasm.